Abigail Jenkins, Gamida Cell CEO
FDA pushes back Gamida Cell’s PDUFA date by three months
Boston-based biotech Gamida Cell will have to wait on the FDA for a little while longer.
The biotech said that in the BLA review for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
